Pages that link to "Q36288920"
Jump to navigation
Jump to search
The following pages link to Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications (Q36288920):
Displayed 16 items.
- Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties (Q33555259) (← links)
- Evaluation of novel large cut-off ultrafiltration membranes for adenovirus serotype 5 (Ad5) concentration. (Q35535220) (← links)
- The use of recombinant adeno-associated virus for skeletal gene therapy (Q36729692) (← links)
- Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency (Q37313583) (← links)
- Relation of structure to performance characteristics of monolithic and perfusive stationary phases (Q37364353) (← links)
- Downstream processing of cell culture-derived virus particles (Q37944322) (← links)
- A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles. (Q38341551) (← links)
- Adeno-Associated Virus Gene Therapy for Liver Disease (Q38789554) (← links)
- Standard free droplet digital polymerase chain reaction as a new tool for the quality control of high-capacity adenoviral vectors in small-scale preparations. (Q38914385) (← links)
- Production and titering of recombinant adeno-associated viral vectors (Q42575413) (← links)
- Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography (Q44197060) (← links)
- Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies (Q45354893) (← links)
- Development of a platform process for adenovirus purification that removes human SET and nucleolin and provides high purity vector for gene delivery (Q45882344) (← links)
- Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C. (Q47100523) (← links)
- Ultrafiltered recombinant AAV8 vector can be safely administered in vivo and efficiently transduces liver. (Q54241222) (← links)
- Vaccine development for human mastadenovirus (Q64376739) (← links)